GPAT4 and depressive symptom measurement: In conclusion, we demonstrate that hippocampal GPAT4 might participate in HFD induced depression by activating AMPK, CREB and BDNF pathways, which provides insights into a clinical target for obesity-associated depression intervention (Figure 8).